Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2006; 12(38): 6182-6187
Published online Oct 14, 2006. doi: 10.3748/wjg.v12.i38.6182
Table 2 VEGF, VEGFR-1 and 2 expression and categories for GISTs (n = 33) n (%)
Totaln
VEGF
VEGFR-1
VEGFR-2
-
+
-
+
-
+
33726924330
Risk categoriesNSNSNS
High40 (0.0)4 (100)0 (0.0)4 (100)0 (0.0)4 (100)
Intermediate51 (20.0)4 (80.0)2 (40.0)3 (60.0)0 (0.0)5 (100)
Low173 (17.6)14 (82.4)5 (29.4)12 (70.6)2 (11.8)15 (88.2)
Very low73 (42.9)4 (57.1)2 (28.6)5 (71.4)1 (14.3)6 (85.7)
Mitosis counts (per 50 fields, HPF)NSNSNS
< 2174 (23.5)13 (76.5)6 (35.3)11 (64.7)2 (11.8)15 (88.2)
2-582 (25.0)6 (75.0)3 (37.5)5 (62.5)1 (12.5)7 (87.5)
6-1041 (25.0)3 (75.0)0 (0.0)4 (100)0 (0.0)4 (100)
>1040 (0.0)4 (100)0 (0.0)4 (100)0 (0.0)4 (100)
Tumour size (cm in length)NSNSNS
< 263 (50.0)3 (50.0)2 (33.3)4 (66.7)1 (16.7)5 (83.3)
2-< 5203 (15.0)17 (85.0)5 (25.0)15 (75.0)2 (10.0)18 (90.0)
5-< 1061 (16.7)5 (83.3)2 (33.3)4 (66.7)0 (0.0)6 (100)
> 1010 (0.0)1 (100)0 (0.0)1 (100)0 (0.0)1 (100)